reference/11790035

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11790035

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	11
issn	0022-3565
issueIdentifier	1
pageRange	400-11
publicationName	The Journal of pharmacology and experimental therapeutics
startingPage	400
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9a4da5c89b468c7fe5c06d512d1aad8e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f34a7776fd6107cdd085504aab120d9c
bibliographicCitation	Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther. 1997 Apr;281(1):400–11. PMID: 9103523.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31b917a994301c1773e182d43b0fe81d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec909596d1fab33ceed28162a8ee2537 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b963d695021f36deaad4778bf8c11dfc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_573b5238d23db70a34e9cb815ae0101b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19522bec1f5a524280db8627e9939ad0
date	199704
identifier	https://pubmed.ncbi.nlm.nih.gov/9103523
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5173 https://portal.issn.org/resource/ISSN/0022-3565
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro
discusses	http://id.nlm.nih.gov/mesh/M0027998 http://id.nlm.nih.gov/mesh/M0009773 http://id.nlm.nih.gov/mesh/M0028857 http://id.nlm.nih.gov/mesh/M0018641
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006221Q000378 http://id.nlm.nih.gov/mesh/D018685Q000378 http://id.nlm.nih.gov/mesh/D019392Q000502
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011994Q000494 http://id.nlm.nih.gov/mesh/D019392Q000235 http://id.nlm.nih.gov/mesh/D066298 http://id.nlm.nih.gov/mesh/D010084 http://id.nlm.nih.gov/mesh/D008862Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8596 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e91b6e4e058c72cc3cb9fa8b1870b976 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2997 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c25c5bef0fa0efbec10a882f149a99d6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3406 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3562 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.14.14.1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28343 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bb8f53d98054f5b6d60889d54b1ea61c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229587 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788599 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790693 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788606 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790690 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790292

Total number of triples: 56.